LAS101057
CAS: 925676-48-8
Ref. 3D-AMB67648
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
LAS101057
Beschreibung:
LAS101057 is a drug candidate that inhibits the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol in the liver. LAS101057 has been shown to have potential therapeutic effects on symptoms associated with insulin resistance and hyperresponsiveness in animal models. This drug has also been shown to reduce inflammation and increase adenosine levels in human fibroblasts. LAS101057 is currently being studied as a treatment for Alzheimer's disease and anxiety disorders. This drug also blocks the A2A receptor and reduces neuronal death after brain injury, suggesting it may be used to treat strokes.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
335.34 g/mol
Formel:
C18H14FN5O
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
